Bill Gates-Led Foundation Awards Dundee-Based Biotech PhaSER $2.7 Million as Company Develops AI for Drug Research
A Dundee biotechnology company developing artificial intelligence to predict harmful interactions between medicines has secured a further $2.7 million (£2 million) from the Gates Foundation, bringing renewed attention to the expanding role of Bill Gates’s philanthropic organisation in medical research and AI technology. PhaSER